Alexis Sharabaika

Alexis Sharabaika currently serves as Senior Director of Market Access Pricing & Contracting at Intellia Therapeutics, Inc., beginning in April 2025. Prior experience includes the role of Executive Director, Market Access Pricing Strategy & Operations at KalVista Pharmaceuticals, Inc., from July 2024 to March 2025, and Senior Director of Pricing and Contracting, Market Access at Sage Therapeutics from July 2019 to July 2024. Earlier positions include Senior Principal and Senior Director in Pricing, Contracting, and Market Access practices at HighPoint Solutions from May 2012 to June 2019, and Senior Consultant at Computer Sciences Corporation from May 2006 to May 2008. Alexis Sharabaika holds a BA in International Relations & French from Tufts University and an MBA in Marketing from the University of Maryland - Robert H. Smith School of Business.